Aldesleukin Completed Phase 3 Trials for Regional Neuroblastoma / Localized Unresectable Neuroblastoma / Localized Resectable Neuroblastoma / Disseminated Neuroblastoma / Stage 4 Neuroblastoma / Stage 4S Neuroblastoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01041638Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma